Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.
about
Permissive role of nitric oxide in endothelin-induced migration of endothelial cellsSecretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cellsMethods for analysis of matrix metalloproteinase regulation of neutrophil-endothelial cell adhesionVascular endothelial dysfunction and pharmacological treatmentThe Role of the Endothelin System in the Vascular Dysregulation Involved in Retinitis PigmentosaPhysiological antagonism of endothelin-1 in human conductance and resistance coronary arteryEvidence for a role of endothelin 1 and protein kinase C in nitroglycerin toleranceEndothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient miceProtective effects of tanshinone ⅡA on endothelial progenitor cells injured by tumor necrosis factor-α.Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery diseaseRetinal vein occlusions: The potential impact of a dysregulation of the retinal veinsHigh frequency rotational ablation: an alternative in treating coronary artery stenoses and occlusionsRaised plasma endothelin in unstable angina and non-Q wave myocardial infarction: relation to cardiovascular outcomeET-1 plasma levels and ocular blood flow in retinitis pigmentosa.Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults.Telomere length and replicative aging in human vascular tissues.A pivotal role of nitric oxide in endothelial cell dysfunction.Tendency to angry rumination predicts stress-provoked endothelin-1 increase in patients with coronary artery diseaseEndothelin-1 impairs nitric oxide signaling in endothelial cells through a protein kinase Cdelta-dependent activation of STAT3 and decreased endothelial nitric oxide synthase expression.Testing for endothelial dysfunction.Endothelial function as a functional expression of cardiovascular risk factors.Evidence for the endothelin system as an emerging therapeutic target for the treatment of chronic painLong-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis.Alterations in nitric oxide and endothelin-1 bioactivity underlie cerebrovascular dysfunction in ApoE-deficient miceObesity-related inflammation & cardiovascular disease: efficacy of a yoga-based lifestyle interventionRole of endothelin in human hypertension.Plasma C-terminal pro-endothelin-1 is associated with target-organ damage in African Americans with hypertension.Endothelial dysfunction in the pathogenesis of atherosclerosis.Endothelial function, endothelin-1, and fibrinogen in young women using the vaginal contraceptive ring.Depression predicts elevated endothelin-1 in patients with coronary artery disease.Endothelin-1 and endothelin receptor antagonists as potential cardiovascular therapeutic agents.Endothelin receptor antagonists in cardiology clinical trials.Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusionThe therapeutic potential of endothelin-1 receptor antagonists and endothelin-converting enzyme inhibitors on the cardiovascular system.Autonomic contribution to endothelin-1 increase during laboratory anger-recall stress in patients with coronary artery diseaseEndothelin receptor expression and pharmacology in human saphenous vein graft.Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor.Orphan nuclear receptor Nur77 is a novel negative regulator of endothelin-1 expression in vascular endothelial cells.CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators.Plasma endothelin-1 concentrations in patients with retinal vein occlusions.
P2860
Q24313558-B122E072-0C1E-4FE4-942A-C8E5FA9405F3Q24552364-AA38837E-EF4F-42FF-A94D-FE0C6251D085Q24797480-6FA671D2-D929-48FB-8FFD-A40F05B9703FQ26774561-8952BA43-0315-4230-A301-FB2B5D7E2A57Q26776382-8494D3EF-84C0-46F7-821D-B9F48510ABCAQ28366585-6DE75443-35E5-4BBF-8062-9B90CEE6B1A5Q28367691-C6DE1F3D-BA2B-4249-80B1-754FBDA59926Q28584822-AF9B055E-FD97-4EF2-888B-04D8E0C255E3Q29347118-808AEF89-94B9-4CE5-A6F4-1009D6B45E98Q31110191-F1EBAB4A-D37F-49C9-840A-DB4513F8AD90Q33393778-D5B1A93F-50A3-418F-A7C3-87718EB30CE0Q33613429-7FFF9DBE-D7EF-4771-A8D7-A14EBBA6B52DQ33614332-30341DF7-F921-4479-A54D-7DE79DB14341Q33632123-C778D5AB-F694-4816-B343-621BD9A60A93Q33686561-10B7048C-4A37-467A-A778-B013E3F401B0Q33763501-9BEFDA4B-651A-4E4A-97A3-DEA131B5D189Q33848393-F87687BE-4F9D-43F7-A27C-6CC823E6B874Q33857649-1E19D81D-9F54-4111-A021-DDCA263D99D4Q33892724-FFCB8823-F5A8-4456-9F84-C9B700292F0CQ34008359-C05CC59E-7E74-456B-96CA-417836332B22Q34027133-59F2206E-5AF3-4ABF-B465-A068319022B0Q34140692-744DA3FD-FD6A-4193-B38E-190637D73138Q34157915-CC6A6AF0-59C2-4F7D-B21C-E556B494F73EQ34171317-FB59FC4B-8CD1-4655-8516-9C05EC7C6853Q34186113-1F5D33E1-CEC4-42C9-930D-78C22DDBB375Q34210942-C4CC1686-00D1-4472-9756-AA97270BA1A9Q34213510-27997908-1BE1-45D3-AB27-082DBA5D8E68Q34430443-AAA055D5-720A-46AC-B866-BD7DF0D6D070Q34447839-6E32AF77-25BA-4FDD-9BFF-BA39B8EE4B6DQ34468833-516673F0-516E-41CF-8B20-8B0BA47234AAQ34496108-7491FCA7-A6BB-40CE-AD68-9507B9CD0B03Q34544685-6F0BD369-0CAB-42D8-B0CC-D95546855D10Q34570744-50423B5E-2CF6-452B-A3B1-852FF714DA87Q35001002-4ECC3961-AC4A-4E3F-A77B-9068D135D406Q35017010-B9499ACC-908D-4926-AF27-7DB9D1B98159Q35028439-4025EB75-C873-418D-BDA8-9BF3657A8814Q35028995-8FCEAD42-5F18-47CA-B643-FF7D82DA66DAQ35032724-9C3AD42F-A113-46B3-BFA0-E80DDB3AF1F7Q35047772-BD24B399-3787-45CB-BBF3-2B671D133312Q35304943-B590D53C-D76D-45FE-8799-A72555D73C05
P2860
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.
@en
type
label
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.
@en
prefLabel
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.
@en
P2093
P1476
Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis.
@en
P2093
Burnett JC Jr
Edwards BS
Hallett JW
Heublein DM
Sandberg SM
P304
P356
10.1056/NEJM199110033251404
P407
P577
1991-10-01T00:00:00Z